## Background: Adenoviral gene transfer to adult skeletal muscle is hindered by several major limitations, including host immune responses and maturation-dependent loss of myofiber infectivity. ex vivo gene delivery is more efficient than direct viral injection in surmounting maturation-dependent a
In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
β Scribed by Ronald G. Crystal
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 169 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Crigler-Najjar type 1 disease (CN1) is a rare inherited metabolic disease characterized by complete absence of hepatic UDP-glucuronosyl transferase (UGT1), resulting in high levels of unconjugated bilirubin. CN1 is an attractive candidate disease for gene therapy. Here we show that in vivo neonatal
## Abstract ## Background To develop more efficient nonβviral vectors, we have previously described a novel approach to attach a nuclear localisation signal (NLS) to plasmid DNA, by generating a fusion protein between the tetracycline repressor protein TetR and an SV40 NLS peptide (TetRβNLS). The
This study rcports that recombinant adenovirus-mediated human bone morphogenetic protein-2 gene transfer can induce mesenchymal progenitor cell dillerentialion and bone formation. The recombinant adenovirus with the human hone morphogenetic protein-2 gene was constructed, and mature human bone morph